Combining Poly(ADP)-Ribose Polymerase Inhibitors With Abiraterone in Castration-Resistant Prostate Cancer: Is Biomarker Testing Necessary?

被引：6

作者：

Antonarakis, Emmanuel S. ^{[1
,3
]}

Abida, Wassim ^{[2
]}

机构：

[1] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA

[2] Mem Sloan Kettering Canc Ctr, New York, NY USA

[3] Univ Minnesota, Masonic Canc Ctr, Dept Med, 420 Delaware St SE,MMC 480, Minneapolis, MN 55455 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 18期

关键词：

D O I：

10.1200/JCO.23.00270

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3291 / +

页数：5

共 15 条

[1] Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration [J].

Abida, Wassim ;

Patnaik, Akash ;

Campbell, David ;

Shapiro, Jeremy ;

Bryce, Alan H. ;

McDermott, Ray ;

Sautois, Brieuc ;

Vogelzang, Nicholas J. ;

Bambury, Richard M. ;

Voog, Eric ;

Zhang, Jingsong ;

Piulats, Josep M. ;

Ryan, Charles J. ;

Merseburger, Axel S. ;

Daugaard, Gedske ;

Heidenreich, Axel ;

Fizazi, Karim ;

Higano, Celestia S. ;

Krieger, Laurence E. ;

Sternberg, Cora N. ;

Watkins, Simon P. ;

Despain, Darrin ;

Simmons, Andrew D. ;

Loehr, Andrea ;

Dowson, Melanie ;

Golsorkhi, Tony ;

Chowdhury, Simon .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (32) :3763-+

[2] Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer [J].

Armstrong, Andrew J. ;

Azad, Arun A. ;

Iguchi, Taro ;

Szmulewitz, Russell Z. ;

Petrylak, Daniel P. ;

Holzbeierlein, Jeffrey ;

Villers, Arnauld ;

Alcaraz, Antonio ;

Alekseev, Boris ;

Shore, Neal D. ;

Gomez-Veiga, Francisco ;

Rosbrook, Brad ;

Zohren, Fabian ;

Yamada, Shunsuke ;

Haas, Gabriel P. ;

Stenzl, Arnulf .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (15) :1616-+

[3] Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer [J].

Asim, Mohammad ;

Tarish, Firas ;

Zecchini, Heather I. ;

Sanjiv, Kumar ;

Gelali, Eleni ;

Massie, Charles E. ;

Baridi, Ajoeb ;

Warren, Anne Y. ;

Zhao, Wanfeng ;

Ogris, Christoph ;

McDuffus, Leigh-Anne ;

Mascalchi, Patrice ;

Shaw, Greg ;

Dev, Harveer ;

Wadhwa, Karan ;

Wijnhoven, Paul ;

Forment, Josep V. ;

Lyons, Scott R. ;

Lynch, Andy G. ;

O'Neill, Cormac ;

Zecchini, Vincent R. ;

Rennie, Paul S. ;

Baniahmad, Aria ;

Tavare, Simon ;

Mills, Ian G. ;

Galanty, Yaron ;

Crosetto, Nicola ;

Schultz, Niklas ;

Neal, David ;

Helleday, Thomas .

NATURE COMMUNICATIONS, 2017, 8

[4] Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer [J].

Chi, Kim N. ;

Rathkopf, Dana ;

Smith, Matthew R. ;

Efstathiou, Eleni ;

Attard, Gerhardt ;

Olmos, David ;

Lee, Ji Youl ;

Small, Eric J. ;

Gomes, Andrea J. Pereira De Santana ;

Roubaud, Guilhem ;

Saad, Marniza ;

Zurawski, Bogdan ;

Sakalo, Valerii ;

Mason, Gary E. ;

Francis, Peter ;

Ms, George Wang ;

Wu, Daphne ;

Diorio, Brooke ;

Lopez-Gitlitz, Angela ;

Sandhu, Shahneen .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (18) :3339-+

[5] Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer [J].

Chi, Kim N. ;

Agarwal, Neeraj ;

Bjartell, Anders ;

Chung, Byung Ha ;

Pereira de Santana Gomes, Andrea J. ;

Given, Robert ;

Juarez Soto, Alvaro ;

Merseburger, Axel S. ;

Ozguroglu, Mustafa ;

Uemura, Hirotsugu ;

Ye, Dingwei ;

Deprince, Kris ;

Naini, Vahid ;

Li, Jinhui ;

Cheng, Shinta ;

Yu, Margaret K. ;

Zhang, Ke ;

Larsen, Julie S. ;

McCarthy, Sharon ;

Chowdhury, Simon .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (01) :13-24

[6]

Clarke Noel W, 2022, NEJM Evid, V1, pEVIDoa2200043, DOI 10.1056/EVIDoa2200043

[7] Olaparib for Metastatic Castration-Resistant Prostate Cancer [J].

de Bono, J. ;

Mateo, J. ;

Fizazi, K. ;

Saad, F. ;

Shore, N. ;

Sandhu, S. ;

Chi, K. N. ;

Sartor, O. ;

Agarwal, N. ;

Olmos, D. ;

Thiery-Vuillemin, A. ;

Twardowski, P. ;

Mehra, N. ;

Goessl, C. ;

Kang, J. ;

Burgents, J. ;

Wu, W. ;

Kohlmann, A. ;

Adelman, C. A. ;

Hussain, M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (22) :2091-2102

[8]

Pfizer Inc, 2022, PRESS REL

[9]

Saad F., 2022, ANN ONCOL, V33, pS616, DOI [DOI 10.1016/J.ANNONC.2022.07.1945, 10.1016/j.annonc.2022.07.1945]

[10] Niraparib with androgen receptor-axis-targeted therapy in patients with metastatic castration-resistant prostate cancer: safety and pharmacokinetic results from a phase 1b study (BEDIVERE) [J].

Saad, Fred ;

Chi, Kim N. ;

Shore, Neal D. ;

Graff, Julie N. ;

Posadas, Edwin M. ;

Lattouf, Jean-Baptiste ;

Espina, Byron M. ;

Zhu, Eugene ;

Yu, Alex ;

Hazra, Anasuya ;

De Meulder, Marc ;

Mamidi, Rao N. V. S. ;

Bradic, Branislav ;

Francis, Peter ;

Hayreh, Vinny ;

Rezazadeh Kalebasty, Arash .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 88 (01) :25-37

← 1 2 →